Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Lanari

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Thescientificworldjournal|September 22, 2009
Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical settingAlessia Lanari, Lucilla Parnetti
Frontiers of Neurology and Neuroscience|March 2, 2012
Acute and chronic carotid occlusion syndromesAlessia Lanari, Giorgio Silvestrelli
Frontiers of Neurology and Neuroscience|March 2, 2012
Ventilatory disordersGiorgio Silvestrelli, Alessia Lanari, Andrea Droghetti
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 21, 2008
Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studiesDaniele Tomassoni, Alessia Lanari, Giorgio Silvestrelli, et al.
Mechanisms of Ageing and Development|November 22, 2005
Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's diseaseAlessia Lanari, Francesco Amenta, Giorgio Silvestrelli, et al.
Mechanisms of Ageing and Development|November 9, 2005
Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markersLucilla Parnetti, Alessia Lanari, Giorgio Silvestrelli, et al.
Mechanisms of Ageing and Development|November 10, 2005
Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiologyGiorgio Silvestrelli, Alessia Lanari, Lucilla Parnetti, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Hyperhomocyst(e)inemia: a risk factor for cerebrovascular diseaseLucilla Parnetti, Valeria Caso, Serena Amici, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 13, 2006
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experienceLucilla Parnetti, Giorgio Silvestrelli, Alessia Lanari, et al.
Journal of the Neurological Sciences|March 24, 2009
Nicardipine use in cerebrovascular disease: a review of controlled clinical studiesFrancesco Amenta, Alessia Lanari, Fiorenzo Mignini, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Thescientificworldjournal|September 22, 2009
Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical settingAlessia Lanari, Lucilla Parnetti
Frontiers of Neurology and Neuroscience|March 2, 2012
Acute and chronic carotid occlusion syndromesAlessia Lanari, Giorgio Silvestrelli
Frontiers of Neurology and Neuroscience|March 2, 2012
Ventilatory disordersGiorgio Silvestrelli, Alessia Lanari, Andrea Droghetti
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 21, 2008
Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studiesDaniele Tomassoni, Alessia Lanari, Giorgio Silvestrelli, et al.
Mechanisms of Ageing and Development|November 22, 2005
Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's diseaseAlessia Lanari, Francesco Amenta, Giorgio Silvestrelli, et al.
Mechanisms of Ageing and Development|November 9, 2005
Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markersLucilla Parnetti, Alessia Lanari, Giorgio Silvestrelli, et al.
Mechanisms of Ageing and Development|November 10, 2005
Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiologyGiorgio Silvestrelli, Alessia Lanari, Lucilla Parnetti, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Hyperhomocyst(e)inemia: a risk factor for cerebrovascular diseaseLucilla Parnetti, Valeria Caso, Serena Amici, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 13, 2006
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experienceLucilla Parnetti, Giorgio Silvestrelli, Alessia Lanari, et al.
Journal of the Neurological Sciences|March 24, 2009
Nicardipine use in cerebrovascular disease: a review of controlled clinical studiesFrancesco Amenta, Alessia Lanari, Fiorenzo Mignini, et al.
Pageof 4